Stock Screener App

Frei -

Installieren

80.00

2.04% -1.66

Inhibrx Biosciences Inc (INBX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Inhibrx Biosciences Inc-Aktie (INBX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00% -	0.10	-	0.10	-
Operating Expenses	14.25% 42.90	50.03	46.80	161.00	73.83
Operating Income/Loss	14.07% -42.90	-49.93	-46.80	-160.90	-73.83
Nonoperating Income/Loss	119.87% -0.41	2.063	2.933	2,018.91	-4.885
Income/Loss From Continuing Operations Before Tax	9.51% -43.31	-47.87	-43.86	1,858.01	-78.71
Income Tax Expense/Benefit	-	-	-	0.002	-
Income/Loss From Continuing Operations After Tax	9.51% -43.31	-47.87	-43.86	1,858.01	-78.71
Net Income/Loss	9.51% -43.31	-47.87	-43.86	1,858.01	-78.71
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	6,805% 15.47	0.224	15.47	14.62	54.55
Diluted Average Shares	9,390% 15.47	0.163	15.47	14.81	54.55
Basic Earnings Per Share	44.33% -2.80	-5.03	-2.84	127.10	-1.44
Diluted Earnings Per Share	37.36% -2.80	-4.47	-2.84	125.48	-1.44
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.23

0.68%

INCY

$92.89

0.72%

GMAB

$28.92

0.96%

BNTX

$104.39

0.46%

ONC

$312.02

0.74%

INSM

$182.66

3.82%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters